The U.S. has tallied 8,077 cases of whooping cough in 2025, compared with 3,847 cases in the same period last year, federal ...

"The mpox virus is primarily spread by prolonged close contact, typically skin-to-skin, often during sexual activity.

mResvia’s prescribing information indicates that the vaccine was 78.7% effective at preventing RSV that presents with two or more symptoms at ... and Prevention (CDC) Advisory Committee on ...

The global at-home testing market is poised for remarkable growth, with sales projected to rise from USD 7,789.1 million in 2025 to USD 11,877.8 million by 2035, according to recent market analysis.

Mpox particles have been detected in several wastewater samples in North Carolina, according to the state Department of ...

The North Carolina Department of Health and Human Services is urging the public to be on alert for mpox cases following the ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.